In Vivo · 2019 · 10 citations · 17 references
MedicineCancer BiologyOncologyMolecular OncologyNeoplasiaOncogenesCancer Cell SignalingLaryngeal CancerMalignant NeoplasmsMolecular Classification Of TumorsOncogenic Signaling PathwaysSquamous Cell CarcinomaAlk Fusion GenesEpidermal Growth Factor Receptor SignalingLaryngeal Squamous Cell CarcinomaMolecular Diagnostic MarkersMolecular Prognostic MarkersSquamous Cell Carcinoma Histopathology
BACKGROUND/AIM: Epidermal growth factor receptor (EGFR) acts as an oncogene in malignancies. Our aim was to examine the role of combined EGFR/ anaplastic lymphoma kinase (ALK) expression as molecular markers in laryngeal squamous cell carcinoma (LSCC) patients. MATERIALS AND METHODS: Fifty (n=50) tissue sections derived from twenty-five (n=25) primary LSCCs were analyzed by immunohistochemistry (IHC). RESULTS: EGFR overexpression was observed in 17/25 (68%) cases. Concerning ALK, 23/25 (92%) demonstrated low expression. EGFR expression was associated with grade (p=0.049), whereas ALK expression was correlated with stage (p=0.048). ALK overexpression was detected at advanced-stage EGFR-positive cases. A biphasic EGFR protein expression pattern was observed in five (n=5) LSCC cases, whereas ALK expression was stable in all cases. CONCLUSION: EGFR overexpression is frequently observed in LSCC combined with low ALK expression. LSCC patients with EGFR/ALK protein overexpression should be eligible for targeted therapeutic strategies.
17
Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer
Alice T. Shaw, Dong-Wan Kim, Ranee Mehra et al. · New England Journal of Medicine · 2014 · 1.5K citations
Medicine, Oncology, Pharmacology +14
The landscape and therapeutic relevance of cancer-associated transcript fusions
Kosuke Yoshihara, Qing Wang, Wandaliz Torres‐García et al. · Oncogene · 2014 · 458 citations · Full text